You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Pelvic exenteration surgery offers a 33% 5-year survival rate for advanced pelvic malignancies, even for recurrent cases. Improved surgical techniques and patient management have significantly reduced operative mortality.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: